Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00466) | |||||
---|---|---|---|---|---|
Name |
Nicotinic acid
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
nicotinic acid; niacin; 59-67-6; Pyridine-3-carboxylic acid; 3-pyridinecarboxylic acid; 3-Carboxypyridine; wampocap; Niaspan; Apelagrin; Pellagrin; Akotin; Daskil; Efacin; Pelonin; Acidum nicotinicum; nicamin; nicobid; nicocap; nicolar; Enduracin; Nicodelmine; Niconacid; Nicotinipca; Pellagramin; Direktan; Nicacid; Nicangin; Peviton; vitamin B3; Bionic; Diacin; Nyclin; Vitaplex N; Davitamon PP; Nico-Span; Tega-Span; Nicocidin; Nicocrisina; Niconazid; Nicoside; Nicotamin; Nicotene; Nicovasan; Nicovasen; Nipellen; SK-Niacin; Naotin; Nicodan; Nicodon; Niconat; Nicosan 3; Nicosyl; Nicotil; 3-Carboxylpyridine; Nicotine acid; Niacor; Slo-niacin; Nicotinsaure; Nico-400; Acide nicotinique; 3-Picolinic acid; Pyridine-beta-carboxylic acid; Nicagin; anti-Pellagra vitamin; Caswell No. 598; PP Factor; Kyselina nikotinova; P.P. factor; Pellagra preventive factor; Nicotinsaure [German]; Acido nicotinico; 3-Pyridylcarboxylic acid; m-Pyridinecarboxylic acid; Kyselina nikotinova [Czech]; MFCD00006391; niacine; CCRIS 1902; Pyridine-carboxylique-3; EPA Pesticide Chemical Code 056701; Acide nicotinique [INN-French]; Acido nicotinico [INN-Spanish]; Acidum nicotinicum [INN-Latin]; HSDB 3134; Pyridine-carboxylique-3 [French]; AI3-18994; Pyridinecarboxylic acid, 3-; Niacin [USP]; SR 4390; BRN 0109591; UNII-2679MF687A; CHEMBL573; beta-pyridinecarboxylic acid; MLS000069603; Pyridine-.beta.-carboxylic acid; CHEBI:15940; Niacin (USP); 2679MF687A; NSC-169454; P.P. factor-pellagra preventive factor; CAS-59-67-6; NCGC00016268-02; SMR000059024; DSSTox_CID_932; Nicotinic acid, 99.5%; [5, 6-3H]-niacin; DSSTox_RID_75875; DSSTox_GSID_20932; Niacin [USAN]; Niacin (nicotinic acid); SR-01000722017; EINECS 200-441-0; NIASPAN TITRATION STARTER PACK; NSC 169454; pellagra; Nikotinsaeure; Ncotnc acd; Nicotinic acid, specified according to the requirements of Ph. Eur; preventative factor; antipellagra vitamin; Niaspan (TN); 3PyrCOOH; [3H]nicotinic acid; Niacor (TN); Nicotinic Acid,(S); PubChem2594; [3H]-Nicotinic acid; Nicotinic acid [INN]; Spectrum_001063; 3-Pyridinecarboxylicacid; Nicotinic acid, Ph Eur; 5-pyridinecarboxylic acid; Opera_ID_1346; Prestwick0_000881; Prestwick1_000881; Prestwick2_000881; Prestwick3_000881; Pyridine-3-carbonic acid; Spectrum2_000006; Spectrum3_000515; Spectrum4_000965; Spectrum5_001287; 3-Pyridyl carboxylic acid; Nicotinic acid-d3(major); ACMC-1AS6M; WLN: T6NJ CVQ; 3-pyridine carboxylic acid; bmse000104; Nicotinic acid, >=98%; EC 200-441-0; SCHEMBL1433; Oprea1_514398; BSPBio_000662; BSPBio_002069; KBioGR_001309; KBioSS_001543; 5-22-02-00057 (Beilstein Handbook Reference); BIDD:GT0644; DivK1c_000695; Nicotinic acid (JP17/INN); SPECTRUM1500430; .beta.-Pyridinecarboxylic acid; SPBio_000011; SPBio_002881; BPBio1_000730; GTPL1588; GTPL1594; ZINC1795; DTXSID1020932; BDBM23515; HMS502C17; KBio1_000695; KBio2_001543; KBio2_004111; KBio2_006679; KBio3_001569; ABT-919; NINDS_000695; HMS1570B04; HMS1920P17; HMS2091H22; HMS2097B04; HMS2236A05; HMS3259K21; HMS3371E07; HMS3655K08; HMS3714B04; Pharmakon1600-01500430; Nicotinic acid, analytical standard; BCP16301; HY-B0143; STR00112; Tox21_110337; Tox21_201420; Tox21_302904; ANW-75276; BBL037343; CCG-38340; Nicotinic acid, for synthesis, 99%; NSC169454; NSC757241; SBB004279; STK301803; Nicotinic acid (Vitamin B3) solution; AKOS000118980; Nicotinic acid, >=99.5% (HPLC); Tox21_110337_1; AM81316; CS-1946; DB00627; EBD2198325; MCULE-3788394698; NC00524; Nicotinic Acid 1.0 mg/ml in Methanol; NSC-757241; PS-4255; SDCCGMLS-0066610.P001; IDI1_000695; NCGC00016268-01; NCGC00016268-03; NCGC00016268-04; NCGC00016268-05; NCGC00016268-08; NCGC00016268-09; NCGC00094734-01; NCGC00094734-02; NCGC00256537-01; NCGC00258971-01; AC-22484; AK-46486; BP-21419; NCI60_001041; Nicotinic acid, NIST(R) SRM(R) 148; Nicotinic acid, plant cell culture tested; ST097540; SY011111; SBI-0051456.P003; DB-007765; Nicotinic Acid [Matrix for MALDI-TOF/MS]; AB00052050; FT-0600004; FT-0672715; FT-0672716; FT-0672717; FT-0672718; FT-0773496; Nicotinic acid 10 microg/mL in Acetonitrile; Nicotinic acid, purum, >=99.0% (HPLC); SW197229-3; C00253; D00049; M-5918; Nicotinic acid, SAJ special grade, >=99.5%; 11054-EP2269610A2; 11054-EP2269990A1; 11054-EP2270002A1; 11054-EP2270014A1; 11054-EP2272825A2; 11054-EP2272834A1; 11054-EP2272848A1; 11054-EP2274983A1; 11054-EP2275401A1; 11054-EP2277848A1; 11054-EP2280001A1; 11054-EP2289510A1; 11054-EP2292228A1; 11054-EP2292610A1; 11054-EP2295406A1; 11054-EP2295409A1; 11054-EP2295424A1; 11054-EP2298742A1; 11054-EP2298772A1; 11054-EP2298776A1; 11054-EP2298779A1; 11054-EP2301923A1; 11054-EP2301929A1; 11054-EP2301935A1; 11054-EP2301937A1; 11054-EP2305651A1; 11054-EP2305674A1; 11054-EP2308838A1; 11054-EP2308839A1; 11054-EP2308848A1; 11054-EP2308854A1; 11054-EP2308858A1; 11054-EP2308874A1; 11054-EP2311808A1; 11054-EP2311816A1; 11054-EP2311817A1; 11054-EP2311829A1; 11054-EP2311830A1; 11054-EP2314588A1; 11054-EP2316457A1; 11054-EP2316458A1; 11054-EP2316825A1; 11054-EP2316826A1; 11054-EP2316827A1; 11054-EP2316828A1; AB00052050-13; AB00052050_14; AB00052050_15; Nicotinic acid, meets USP testing specifications; AC-907/25014105; L001199; Nicotinic acid, Vetec(TM) reagent grade, >=98%; Q134658; J-523605; SR-01000722017-2; SR-01000722017-3; SR-01000722017-4; Z56755709; 3DDB011E-F3A6-45B6-A2D2-77B2A6E8936E; F2191-0082; Niacin, United States Pharmacopeia (USP) Reference Standard; Nicotinic acid, certified reference material, TraceCERT(R); Nicotinic acid, European Pharmacopoeia (EP) Reference Standard; Nicotinic acid, matrix substance for MALDI-MS, >=99.5% (HPLC); Nicotinic acid, for inorganic trace analysis, >=99.999% (metals basis); 101113-41-1
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Lung cancer | ICD-11: 2C25 | [1] | ||
PubChem CID | |||||
Formula |
C6H5NO2
|
||||
Canonical SMILES |
C1=CC(=CN=C1)C(=O)O
|
||||
InChI |
1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)
|
||||
InChIKey |
PVNIIMVLHYAWGP-UHFFFAOYSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=938"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 123.11 | Topological Polar Surface Area | 50.2 | |
XlogP | 0.4 | Complexity | 114 | ||
Heavy Atom Count | 9 | Rotatable Bond Count | 1 | ||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 3 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Nicotinic acid 1000 mg tablet | Click to Show/Hide the Full List of Formulation(s): 12 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium stearyl fumarate; Ferric oxide red; Ferric oxide yellow; Talc; Titanium dioxide; Lecithin, soybean; Polyethylene glycol 1000; Silicon dioxide; Hydroxypropyl cellulose (type e); Polyvinyl alcohol, unspecified
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Lannett Company | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [2] | |||
Polyethylene glycol 1000 | DIG Info | Cytochrome P450 2E1 (IC50 = 75.3 uM) | [3] | |||
Soybean lecithin | DIG Info | Albendazole monooxygenase (IC50 = 6.61 mg.mL-1) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Povidone; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Lupin Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [3] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Povidone; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Lupin Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [3] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Polyethylene glycol 400; Hydroxyethyl cellulose (4000 cps at 1%); Hypromelloses
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Marlex Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Polyethylene glycol 400 | DIG Info | Albendazole monooxygenase (IC50 = 10.77 mg.mL-1) | [4] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Polyethylene glycol 400; Hydroxyethyl cellulose (4000 mpa.s at 1%); Hypromelloses
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Amneal Pharmaceuticals; AvPAK; Avera McKennan Hospital | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Polyethylene glycol 400 | DIG Info | Albendazole monooxygenase (IC50 = 10.77 mg.mL-1) | [4] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Povidone; Hypromelloses; Polyethylene glycol
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Lake Eire Medical & Surgical Supply DBA Quality Care Products; Rebel Distributors | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [3] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Povidone; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Dispensing Solution; Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [3] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Povidone; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | AbbVie | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [3] | |||
Drug Formulation 9 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Silicon dioxide; Hypromellose, unspecified; Microcrystalline cellulose; Polyethylene glycol, unspecified; Povidone, unspecified
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | American Health Packaging | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 10 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Aluminum oxide; Hypromelloses; Polyethylene glycols; Povidones
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Zydus Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Drug Formulation 11 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Hypromellose 2910 (10000 mpa.s); Povidone k90
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | AvKARE; Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Drug Formulation 12 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Glyceryl dibehenate; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Talc; Titanium dioxide; Polyvinyl alcohol; Silicon dioxide; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Avera McKennan Hospital; Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Nicotinic acid 500 mg tablet | Click to Show/Hide the Full List of Formulation(s): 16 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium stearyl fumarate; Ferric oxide red; Ferric oxide yellow; Talc; Titanium dioxide; Lecithin, soybean; Polyethylene glycol 1000; Silicon dioxide; Hydroxypropyl cellulose (type e); Polyvinyl alcohol, unspecified
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Lannett Company | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [2] | |||
Polyethylene glycol 1000 | DIG Info | Cytochrome P450 2E1 (IC50 = 75.3 uM) | [3] | |||
Soybean lecithin | DIG Info | Albendazole monooxygenase (IC50 = 6.61 mg.mL-1) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Povidone; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Lupin Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [3] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Povidone; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Lupin Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [3] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Polyethylene glycol 400; Hydroxyethyl cellulose (4000 cps at 1%); Hypromelloses
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Marlex Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Polyethylene glycol 400 | DIG Info | Albendazole monooxygenase (IC50 = 10.77 mg.mL-1) | [4] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Polyethylene glycol 400; Hydroxyethyl cellulose (4000 mpa.s at 1%); Hypromelloses
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Amneal Pharmaceuticals; AvPAK; Avera McKennan Hospital | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Polyethylene glycol 400 | DIG Info | Albendazole monooxygenase (IC50 = 10.77 mg.mL-1) | [4] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Povidone; Hypromelloses; Polyethylene glycol
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Dispensing Solution; Lake Eire Medical & Surgical Supply DBA Quality Care Products; Rebel Distributors | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [3] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Povidone; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [3] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Silicon dioxide; Hypromellose, unspecified; Microcrystalline cellulose; Polyethylene glycol, unspecified; Povidone, unspecified
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Bryant Ranch Prepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 9 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Silicon dioxide; Hypromellose, unspecified; Microcrystalline cellulose; Polyethylene glycol, unspecified; Povidone, unspecified
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | American Health Packaging | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 10 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Aluminum oxide; Hypromelloses; Polyethylene glycols; Povidones
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Zydus Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Drug Formulation 11 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Hypromellose, unspecified; Polyethylene glycol, unspecified; Povidone, unspecified
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | A-S Medication Solutions | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Drug Formulation 12 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Hypromelloses; Polyethylene glycols; Povidones
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | AbbVie | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Drug Formulation 13 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Hypromelloses; Polyethylene glycols; Povidones
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Carilion Materials Management | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Drug Formulation 14 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Hypromellose 2910 (10000 mpa.s); Povidone k90
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | AvKARE; Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Drug Formulation 15 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Glyceryl dibehenate; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Talc; Titanium dioxide; Polyvinyl alcohol; Silicon dioxide; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Avera McKennan Hospital; Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 16 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Croscarmellose sodium; Hydrogenated soybean oil; Microcrystalline cellulose
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Avondale Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Nicotinic acid 750 mg tablet | Click to Show/Hide the Full List of Formulation(s): 11 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Povidone; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Lupin Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [3] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Povidone; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Lupin Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [3] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Povidone; Hypromelloses; Polyethylene glycol
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [3] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Povidone; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [3] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Povidone; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | AbbVie | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [3] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Aluminum oxide; Hypromelloses; Polyethylene glycols; Povidones
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Zydus Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Hydroxyethyl cellulose (4000 cps at 1%); Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Marlex Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Hydroxyethyl cellulose (4000 mpa.s at 1%); Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Amneal Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Drug Formulation 9 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Fd&c yellow no. 6; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Hypromelloses; Polyethylene glycols; Povidones
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Carilion Materials Management | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Drug Formulation 10 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Hypromellose 2910 (10000 mpa.s); Povidone k90
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [6] | |||
Drug Formulation 11 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Glyceryl dibehenate; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Talc; Titanium dioxide; Polyvinyl alcohol; Silicon dioxide; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Nicotinic acid 250 mg capsule | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Riboflavin; Fd&c yellow no. 6; Sucrose; Talc; Fd&c green no. 3; Gelatin; Starch, corn; Turmeric
|
|||||
Dosage Form | Extended Release Oral Capsule | |||||
Company | Time Cap Labs | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Riboflavin | DIG Info | Riboflavin-binding protein (Ki = 350 nM) | [8] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [7] | |||
Nicotinic acid 500 mg capsule | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 1; Sucrose; Talc; Titanium dioxide; Gelatin; Shellac
|
|||||
Dosage Form | Extended Release Oral Capsule | |||||
Company | Time Cap Labs | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [7] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.